Free Trial

Aquestive Therapeutics (AQST) SEC Filings & 10K Form

Aquestive Therapeutics logo
$4.44 -0.13 (-2.84%)
(As of 11/15/2024 ET)

Recent Aquestive Therapeutics SEC Filings

DateFilerForm TypeView
11/04/2024
3:40 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:42 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
7:05 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
7:06 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/16/2024
4:16 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
1:14 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4/A
10/02/2024
1:15 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4/A
10/02/2024
1:15 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4/A
10/02/2024
1:16 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4/A
09/27/2024
7:46 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:56 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:08 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
1:45 PM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:26 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
7:16 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:32 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:14 PM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 3/A
06/11/2024
11:35 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2024
11:36 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:13 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
12:40 PM
Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
12:40 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:08 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:21 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:23 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
8:30 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
8:20 AM
Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2024
5:23 AM
Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/24/2024
5:25 AM
Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/23/2024
11:15 PM
Aquestive Therapeutics (Filer)
Form EFFECT
04/03/2024
4:27 PM
Aquestive Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/01/2024
5:21 PM
Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
04/01/2024
7:15 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
1:30 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

03/14/2024
8:56 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
12:45 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:46 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:46 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:34 AM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:36 AM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:36 AM
Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:36 AM
Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:09 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
4:12 PM
Aquestive Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
2:24 PM
Aquestive Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
12/08/2023
9:46 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
7:51 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AQST) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners